Vpr蛋白凋亡在HIV-1中的数据挖掘分析
摘要
关键词
全文:
PDF参考
[1]AIDS, Hepatitis C Professional Group SoID, Chinese Medical Association, Control CCfD, Prevention. Chinese guidelines for the diagnosis and treatment of HIV/AIDS (2021 edition)[J].Infectious Diseases Immunity,2022;2(03):145-67.
[2]World Health Organization. HIV/AIDS. (2021-07-17)Available from: https://www.who.int/news-room/fact-sheets/detail/hiv-aids[J].Accessed September 5,2021.
[3]Safreed-Harmon K, Anderson J, Azzopardi-Muscat N, Behrens GM, Monforte AdA, Davidovich U, et al. Reorienting health systems to care for people with HIV beyond viral suppression[J]. The Lancet HIV,2019,6(12):e869-e77.
[4]Ding Y, Ma Z, He J, Xu X, Qiao S, Xu L, et al. Evolving HIV epidemiology in mainland China: 2009–2018[J].Current HIV/AIDS Reports,2019;16:423-30.
[5]Mbita Z, Hull R, Dlamini Z. Human immunodeficiency virus-1 (HIV-1)-mediated apoptosis: new therapeutic targets[J]. Viruses,2014,6(8):3181-227.
[6]Moon HS, Yang J-S. Role of HIV Vpr as a regulator of apoptosis and an effector on bystander cells[J]. Molecules Cells,2006,21(1).
[7]Badley AD, Sainski A, Wightman F, Lewin SR. Altering cell death pathways as an approach to cure HIV infection[J].Cell death disease,2013,4(7):e718-e.
[8]Fernández Larrosa PN, Croci DO, Riva DA, Bibini M, Luzzi R, Saracco M, et al. Apoptosis resistance in HIV-1 persistently-infected cells is independent of active viral replication and involves modulation of the apoptotic mitochondrial pathway[J].Retrovirology,2008;5:1-12.
[9]Zhou H-y, Zheng Y-h, He Y, Chen Z, He B. The role of autophagy in THP-1 macrophages resistance to HIV-vpr-induced apoptosis[J]. Experimental Cell Research, 2017,351(1):68-73.
[10]González ME. The HIV-1 Vpr protein: a multifaceted target for therapeutic intervention[J]. International journal of molecular sciences,2017,18(1):126.
[11]Fabryova H, Strebel K. Vpr and its cellular interaction partners: R we there yet[J].Cells,2019;8(11):1310.
[12]Wallet C, Rohr O, Schwartz C. Evolution of a concept: From accessory protein to key virulence factor, the case of HIV-1 Vpr[J].Biochemical Pharmacology.2020,180:114128.
[13]王芳,李明,张华.HIV-1感染与宿主细胞免疫应答机制的研究进展[J].中国免疫学杂志,2020,36(15):1897-1901.
[14]Li J, Lei W-T, Zhang P, Rapaport F, Seeleuthner Y, Lyu B, et al. Biochemically deleterious human NFKB1 variants underlie an autosomal dominant form of common variable immunodeficiency[J]. Journal of Experimental Medicine. 2021,218(11):e20210566.
[15]Yang J, Sevkoplyas A, Podsvirova S, Tyshevich A, Wang M, Lee M, et al. 1982P Transcriptomic analysis and tumor microenvironment (TME) classification reveals unique immune biology in HIV patients with Kaposi sarcoma (KS)[J].2023,34:S1057.
[16]Li L-L, Dai B, Sun Y-H, Zhang T-T. The activation of IL-17 signaling pathway promotes pyroptosis in pneumonia-induced sepsis[J]. Annals of Translational Medicine,2020;8(11).
[17]Ma H-Y, Xu J, Liu X, Zhu Y, Gao B, Karin M, et al. The Role of IL-17 Signaling in Regulation of the Liver–Brain Axis and Intestinal Permeability in Alcoholic Liver Disease[J].Current pathobiology reports,2016,4:27-35.
[18]张红健.pEGFP-N1-IL-17通过调控Fas/FasL信号通路影响喉癌Hep-2细胞的凋亡[J].安徽医科大学学报.2019;54(11):5.
[19]张春江,杨平荣,马毅.自身免疫病治疗的新型靶点:Act1介导的IL-17信号通路[J].免疫学杂志.2012;28(5):4.
(0 摘要 Views, 0 PDF Downloads)
Refbacks
- 当前没有refback。